Skip to main content
Open this photo in gallery:

CanniMed CEO Brent Zettl is photographed in Toronto on Monday, Dec. 11, 2017.Chris Young/The Canadian Press

CanniMed Therapeutics, which is being acquired by Aurora Cannabis, said Chief Executive Officer Brent Zettl has resigned.

Aurora Cannabis senior vice president André Jérôme, previously tasked with heading the acquisition of CanniMed, will serve as interim CEO.

Aurora is almost set to close the purchase of CanniMed, creating the world’s most valuable weed firm after months of tensions between the companies.

“I would like to express our gratitude to Brent for his leadership of CanniMed over the past three decades,” Chief Financial Officer John Knowles said in a statement.

In a combined statement, the companies said Zettl will assist CanniMed and Aurora in an advisory role through the merger.

Aurora had originally made a hostile bid capped at $24 per share for CanniMed, and increased it to $43.

Report an editorial error

Report a technical issue

Tickers mentioned in this story

Study and track financial data on any traded entity: click to open the full quote page. Data updated as of 27/05/24 4:00pm EDT.

SymbolName% changeLast
Aurora Cannabis Inc

Interact with The Globe